Senestech (SNES) Reaches New 1-Year Low at $0.76
Senestech, Inc. (NASDAQ:SNES) hit a new 52-week low on Monday . The stock traded as low as $0.76 and last traded at $0.82, with a volume of 906300 shares. The stock had previously closed at $0.88.
SNES has been the topic of several recent analyst reports. Craig Hallum set a $3.00 price target on Senestech and gave the stock a “buy” rating in a report on Wednesday, November 22nd. Zacks Investment Research upgraded Senestech from a “sell” rating to a “hold” rating in a report on Friday, September 8th.
The company has a debt-to-equity ratio of 0.17, a current ratio of 2.94 and a quick ratio of 2.67.
A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. White Pine Capital LLC bought a new stake in Senestech during the 2nd quarter valued at $110,000. Skylands Capital LLC boosted its position in Senestech by 139.8% during the 3rd quarter. Skylands Capital LLC now owns 87,483 shares of the company’s stock valued at $162,000 after acquiring an additional 51,000 shares in the last quarter. TCI Wealth Advisors Inc. bought a new stake in Senestech during the 3rd quarter valued at $748,000. Prudential PLC boosted its position in Senestech by 49.3% during the 2nd quarter. Prudential PLC now owns 447,971 shares of the company’s stock valued at $2,661,000 after acquiring an additional 147,971 shares in the last quarter. Finally, Gilder Gagnon Howe & Co. LLC boosted its position in Senestech by 3.0% during the 3rd quarter. Gilder Gagnon Howe & Co. LLC now owns 1,078,499 shares of the company’s stock valued at $1,995,000 after acquiring an additional 31,330 shares in the last quarter. Institutional investors own 14.44% of the company’s stock.
SenesTech, Inc is a United States-based biotechnology platform and research company. The Company is engaged in developing a technology for managing animal populations by fertility control. It offers ContraPest, a fertility control product candidate. ContraPest’s technology and approach targets the reproductive capabilities of both sexes.
Receive News & Stock Ratings for Senestech Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senestech Inc. and related stocks with our FREE daily email newsletter.